About 18-19 vaccines against Covid-19 in the pipeline: Harsh Vardhan

Addressing the media, Vardhan said that in the next 2-3 weeks, vaccinations against Covid-19 will be started for people above 50 years of age

Harsh Vardhan
Health Minister Dr Harsh Vardhan
Press Trust of India New Delhi
1 min read Last Updated : Feb 15 2021 | 6:31 PM IST

About 18-19 vaccine candidates against COVID-19 are in the pipeline and in different clinical trial stages, Health Minister Harsh Vardhan said on Monday.

Addressing the media, Vardhan said that in the next 2-3 weeks, vaccinations against COVID-19 will be started for people above 50 years of age.

"About 18-20 vaccine candidates against COVID-19 are in the pipeline and are in preclinical, clinical and advanced stages," Vardhan said.

He further said that India will be supplying vaccines to 20-25 other countries.

Dispelling rumours surrounding the vaccines, Vardhan said the vaccines in the public domain are safe and effective.

He said no new cases of COVID-19 have been reported in 188 districts of the country in the last 7 days, while no new cases have been reported in 21 districts in 21 days.

Vardhan further urged people to keep following COVID appropriate behaviour.

"It is crucial that people continue to follow COVID appropriate behaviour which I call social vaccine, along with real vaccines," he said.

India has approved two vaccines -- Covaxin developed by Bharat Biotech and Covishield from the Oxford/AstraZeneca stable being manufactured by the Serum Institute of India -- for emergency use in the country.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusHarsh Vardhan

First Published: Feb 15 2021 | 6:31 PM IST

Next Story